Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma
- 30 June 2005
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 31 (5) , 555-558
- https://doi.org/10.1016/j.ejso.2005.01.005
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implicationsBritish Journal of Haematology, 2003
- Nasopharyngeal carcinomasEuropean Journal Of Cancer, 2003
- Osteopontin Stimulates Cell Motility and Nuclear Factor κB-mediated Secretion of Urokinase Type Plasminogen Activator through Phosphatidylinositol 3-Kinase/Akt Signaling Pathways in Breast Cancer CellsJournal of Biological Chemistry, 2003
- Osteopontin Induces Nuclear Factor κB-mediated Promatrix Metalloproteinase-2 Activation through IκBα/IKK Signaling Pathways, and Curcumin (Diferulolylmethane) Down-regulates These PathwaysJournal of Biological Chemistry, 2003
- Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathwaysOncogene, 2003
- Squamous cell carcinomas of the head and neck * Commentary: Head and neck carcinomas in the developing worldBMJ, 2002
- Colocalization of Intracellular Osteopontin With CD44 Is Associated With Migration, Cell Fusion, and Resorption in OsteoclastsJournal of Bone and Mineral Research, 2002
- Plasma osteopontinCancer, 2002
- REGULATION OF NO SYNTHESIS INDUCED BY INFLAMMATORY MEDIATORS IN RAW264.7 CELLS: COLLAGEN PREVENTS INHIBITION BY OSTEOPONTINCytokine, 2000
- Osteopontin expression in lung cancerLung Cancer, 1996